BCL2 and breast cancer: Similarly, a study has shown a reduction of EGFR activation in EPA- or DHA-induced apoptosis in breast cancer (MDA-MB-231 and MCF-7) cells, associated to a reduction of Bcl2 and caspase-8 expression [31].